Trial intelligence / Profile preview

Darbepoetin alfa for Chemotherapy-Induced Anemia in DLBCL

NCT02890602Phase 2Completed

Start
Sep 2012
Primary completion
Nov 2017
01

Overview

A Phase 2 trial of darbepoetin alfa in anemia. Started Sep 2012; status: completed.

02

Drugs

darbepoetin alfa
03

Conditions

anemia

Beyond the preview

Go deeper on NCT02890602.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02890602.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call